Muromachi Chemicals Inc.
4885.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.65B
Close$
Share Statistics
| Market cap | $3.65 Billion |
|---|---|
| Enterprise Value | $3.83 Billion |
| Dividend Yield | $25.00 (2.76%) |
| Earnings per Share | $40.58 |
| Beta | 0.48 |
| Outstanding Shares | 4,013,000 |
Return
| Return on Equity | 6.33% |
|---|---|
| Return on Assets | 2.57% |
| Return on Invested Capital | 19.13% |
Valuation & Multiples
| P/E Ratio | 22.32 |
|---|---|
| PEG | 1.02 |
| Price to Sales | 0.46 |
| Price to Book Ratio | 1.41 |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | 5.14 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.56 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Muromachi Chemicals Inc.
203 employees
CEO: Junichi Aoki Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharma...